2023 Form 5500 filing — Integrated Biopharma, Inc. Employees' Profit Sharing Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241003105342NAL0020375586001) for Integrated Biopharma, Inc. Employees' Profit Sharing Plan, reported by Integrated Biopharma, Inc. under EIN 22-2407475 and plan number 002. It reports 51 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).
- EFAST2 acknowledgement
- 20241003105342NAL0020375586001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Integrated Biopharma, Inc.
- EIN
- 22-2407475
- Plan number
- 002
- Location
- Hillside, NJ
- Participants
- 51
- Schedules available
- Schedule I
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $8,141,672
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $8,141,672
- Employer contributions
- $74,389
- Participant contributions
- $166,616
- Total income / additions
- $1,668,320
- Benefits paid
- $404,213
- Administrative expenses
- $1,732
- Total expenses
- $405,945
- Net increase / (decrease)
- $1,262,375
- Schedule source
- Schedule I